Sign in
4

Changes in Ownership

CytomX Therapeutics, Inc. Filed Acc 0001567619-21-005396

Options or other derivatives

  • President and CEO acquired 600,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

McCarthy Sean A. · President and CEO

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2021-02-26 Grant or award : show line 1 in the form Stock Option (right to buy) +400,000 400,000 D
2021-02-27 Grant or award : show line 2 in the form Stock Option (Right to Buy) +200,000 200,000 D
Loading xslF345X03/doc1.xml…